KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Abbott Laboratories (ABT) Accumulated Depreciation & Amortization (2016 - 2026)

Abbott Laboratories' Accumulated Depreciation & Amortization history spans 18 years, with the latest figure at $13.4 billion for Q1 2026.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 7.0% to $13.4 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $13.4 billion, a 7.0% increase, with the full-year FY2025 number at $13.4 billion, up 10.96% from a year prior.
  • Accumulated Depreciation & Amortization hit $13.4 billion in Q1 2026 for Abbott Laboratories, roughly flat from $13.4 billion in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for ABT hit a ceiling of $13.4 billion in Q4 2025 and a floor of $10.6 billion in Q1 2022.
  • Historically, Accumulated Depreciation & Amortization has averaged $11.9 billion across 5 years, with a median of $11.8 billion in 2024.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: increased 2.57% in 2022 and later increased 10.96% in 2025.
  • Tracing ABT's Accumulated Depreciation & Amortization over 5 years: stood at $11.0 billion in 2022, then rose by 6.6% to $11.8 billion in 2023, then grew by 2.57% to $12.1 billion in 2024, then rose by 10.96% to $13.4 billion in 2025, then dropped by 0.34% to $13.4 billion in 2026.
  • Business Quant data shows Accumulated Depreciation & Amortization for ABT at $13.4 billion in Q1 2026, $13.4 billion in Q4 2025, and $13.3 billion in Q3 2025.